Follow
Jeffrey T. Yap, PhD
Jeffrey T. Yap, PhD
Research Professor, University of Utah
Verified email at hci.utah.edu
Title
Cited by
Cited by
Year
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials
LK Shankar, JM Hoffman, S Bacharach, MM Graham, J Karp, ...
Journal of Nuclear Medicine 47 (6), 1059-1066, 2006
8062006
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin
FS Hodi, CL Corless, A Giobbie-Hurder, JA Fletcher, M Zhu, ...
Journal of clinical oncology 31 (26), 3182, 2013
6712013
PET/CT today and tomorrow
DW Townsend, JPJ Carney, JT Yap, NC Hall
Journal of Nuclear Medicine 45 (1 suppl), 4S-14S, 2004
6082004
Bevacizumab plus ipilimumab in patients with metastatic melanoma
FS Hodi, D Lawrence, C Lezcano, X Wu, J Zhou, T Sasada, W Zeng, ...
Cancer immunology research 2 (7), 632-642, 2014
5592014
Protective autophagy elicited by RAF→ MEK→ ERK inhibition suggests a treatment strategy for RAS-driven cancers
CG Kinsey, SA Camolotto, AM Boespflug, KP Guillen, M Foth, A Truong, ...
Nature medicine 25 (4), 620-627, 2019
5412019
Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas
S George, P Merriam, RG Maki, AD Van den Abbeele, JT Yap, T Akhurst, ...
Journal of Clinical Oncology 27 (19), 3154, 2009
3632009
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
JP Leonard, AS LaCasce, MR Smith, A Noy, LR Chirieac, SJ Rodig, ...
Blood, The Journal of the American Society of Hematology 119 (20), 4597-4607, 2012
3402012
Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial
S George, Q Wang, MC Heinrich, CL Corless, M Zhu, JE Butrynski, ...
Journal of Clinical Oncology 30 (19), 2401, 2012
2882012
New response evaluation criteria in solid tumors (RECIST) guidelines for advanced non–small cell lung cancer: comparison with original RECIST and impact on assessment of tumor …
M Nishino, DM Jackman, H Hatabu, BY Yeap, LA Cioffredi, JT Yap, ...
American journal of roentgenology 195 (3), W221-W228, 2010
2802010
Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET
PA Kaufmann, T Gnecchi-Ruscone, JT Yap, O Rimoldi, PG Camici
Journal of nuclear medicine 40 (11), 1848-1856, 1999
2711999
Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate
HL Anderson, JT Yap, MP Miller, A Robbins, T Jones, PM Price
Journal of Clinical Oncology 21 (15), 2823-2830, 2003
2512003
Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2 …
IA Mayer, VG Abramson, SJ Isakoff, A Forero, JM Balko, MG Kuba, ...
Journal of clinical oncology 32 (12), 1202, 2014
1942014
Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw
N Raje, SB Woo, K Hande, JT Yap, PG Richardson, S Vallet, N Treister, ...
Clinical Cancer Research 14 (8), 2387-2395, 2008
1642008
Intensity modulated radiation therapy: a clinical perspective
AJ Mundt, JC Roeske
PMPH-USA, 2005
1552005
Performance evaluation of the microPET®—FOCUS-F120
R Laforest, D Longford, S Siegel, DF Newport, J Yap
IEEE Transactions on Nuclear Science 54 (1), 42-49, 2007
1192007
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine …
E Ben-Ami, CM Barysauskas, M Von Mehren, MC Heinrich, CL Corless, ...
Annals of Oncology 27 (9), 1794-1799, 2016
1172016
Comparison of four early posttherapy imaging changes (EPTIC; RECIST 1.0, tumor shrinkage, computed tomography tumor density, Choi criteria) in assessing outcome to vascular …
KM Krajewski, M Guo, AD Van den Abbeele, J Yap, N Ramaiya, ...
European urology 59 (5), 856-862, 2011
1162011
F18-fluorodeoxyglucose–positron emission tomography/computed tomography screening in li-Fraumeni syndrome
S Masciari, AD Van den Abbeele, LR Diller, I Rastarhuyeva, J Yap, ...
Jama 299 (11), 1315-1319, 2008
1122008
Image-guided cancer therapy using PET/CT
JT Yap, JPJ Carney, NC Hall, DW Townsend
The Cancer Journal 10 (4), 221-233, 2004
1122004
Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning
M Aristophanous, RI Berbeco, JH Killoran, JT Yap, DJ Sher, AM Allen, ...
International Journal of Radiation Oncology* Biology* Physics 82 (1), e99-e105, 2012
1092012
The system can't perform the operation now. Try again later.
Articles 1–20